Skip to main content
. 2022 Feb 9;12(2):445. doi: 10.3390/diagnostics12020445

Table 2.

RV Longitudinal Strain in HFrEF.

Reference Sample Size Age (Years),
Mean ± SD
Study Design LVEF (%) RVGLS (%) RVFWLS (%) Software Device
Houard et al. [13] 266 60 ± 14 Retrospective 23 ± 7 2D-STE-RVGLS:
−18.0 ± 4.9
CMR-FT-RVGLS:
−11.8 ± 4.3
2D-STE-RVFWLS:
−18.7 ± 6.6
4.6 version; TOMTEC Imaging Systems, Unters chleißheim, Germany Segment version 2.2 (Medviso, Lund, Sweden) Sonus 7500 or iE33 ultrasound systems (Philips Medical Systems, And over, Massachusetts 1.5-T or 3.0-T systems (Intera CV and Achieva, Philips Medical Systems, Best, The Netherlands
Iacoviello et al. [14] 332 64 ± 14 Prospective 33 ± 9 2D-STE-RVGLS:
−14.6 ± 4.6
2D-STE-RVFWLS:
−21.5 ± 6.2
Echo- PAC PC version; GE Vingmed Ultra-sound Vivid 7 (GE Vingmed Ultrasound, General Electric, Milwaukee, WI, USA)
Motoki et al. [84] 171 57 ± 14 Retrospective 25 ± 6 2D-STE-RVGLS:
−12.4 ± 5.5 a
−10.5 ± 5.1 b
Velocity Vector Imaging [VVI]; Siemens Medical Solutions USA, Inc. Acuson Sequoia (Siemens Medical Solutions USA, Inc., Malvern, PA, USA)
Carluccio et al. [85] 288 66 ± 11 Prospective Median
[interquartile range]):
30(25−35)
2D-STE-RVGLS
(median [interquartile range]):
−15.1[−17.9; −10.8] a
−11.3[−15.1; −8.2] b
2D-STE-RVFWLS
(median [interquartile range]):
−20.2[−24.3; −15.6] a
−15.0[−20.0; −11.0] b
EchoPac 113, General Electric-Vingmed Vivid 7, Vivid S6, General Electric-Vingmed, Horton, Norway
Cameli et al. [86] 47 57.4 ± 8.1 c
57.8 ± 7.8 d
Cross-sectional 25.2 ± 4.5 c
24.9 ± 4.7 d
2D-STE-RVGLS:
−18.1 ± 2.1 c
−10.9 ± 1.8 d
2D-STE-RVFWLS:
−20.9 ± 2.8 c
−10.6 ± 1.9 d
EchoPac, GE, Milwaukee, WI, USA
Houard et
al. [87]
20 63 ± 17 Prospective 33 ± 8 2D-STE-RVGLS:
−19 ± 4
CMR-FT-RVGLS:
−11 ± 6
2D-STE-RVFWLS:
−21 ± 6
Tomtec Software (4.6. Version; Tomtec Imaging Systems, Germany)
CVI-42 software (Circle CV, Montreal, QC, Canada).
Philips EPIQ 7 ultrasound system (Philips Medical. Systems, Andover, MA, USA)
3T scanner (Achieva, Philips Medical Systems, Best, The Netherlands).

a Patients without event (cardiovascular death, hospitalization for acute HF, heart transplantation, intra-aortic balloon pump implantation, and ven-tricular assist device implantation); bPatients with event (cardiovascular death, hospitalization for acute HF, heart transplantation, intra-aortic balloon pump implantation, and ventric-ular assist device implantation); c RV stroke work index 0.25 mmHg/Lm2; d RV stroke work index < 0.25 mmHg/Lm2.